{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:37:19Z","timestamp":1757313439593},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hepatitis Delta Virus (HDV) infects only patients that are already infected by hepatitis B virus (HBV) because this is sub satellite virus which depends on and propagate only in the presence of HBV. HDV causes co-infection or super infection with sever complication as compared to only HBV infection. No study on molecular level on HDV is available from this region; therefore, the aim of this study was to found out the molecular epidemiology of HDV (as a co-infection with HBV) in different geographical regions of Pakistan.<\/jats:p>\n          <jats:p>Total 228 HBsAg positive samples were received for the study from different geographical regions of the country. Only HBV DNA PCR positive samples were further utilized for the presence of HDV RNA. For this purpose, HDV RNA and HBV DNA was extracted and amplified using reverse transcriptase polymerase chain reaction (RT-PCR), nested PCR and real-time PCR.<\/jats:p>\n          <jats:p>Out of the total 228 HBsAg positive samples, HBV DNA was detected in total 190 (83.3%) samples belonged to different patients. Of these 190 patients, HDV RNA was observed in 53 (28%) patients. Of the 53 HDV positive cases, 37 (69.8%) were males and 16 (30.2%) were female patients. The percentage of dual infection was found higher significantly (p &lt; 0.05) in male patients as compared to female patients. Total 41 (26.8%) patients were below 40 years and 13 (31.7%) were above 40 years of age. No significant difference was seen in patients with ages above or below 40 years. In the provinces of Sindh, Khyber Pakhtoonkhaw and Punjab the observed prevalence of HDV was 67%, 6% and 4% respectively.<\/jats:p>\n          <jats:p>In conclusion, the HDV infection is not uncommon in Pakistan and its prevalence is higher significantly in the Province of Sindh (p &lt; 0.01) and male six (p &lt; 0.05).<\/jats:p>","DOI":"10.1186\/1743-422x-8-420","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T06:14:58Z","timestamp":1315289698000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach"],"prefix":"10.1186","volume":"8","author":[{"given":"Asad U","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehnaz","family":"Zaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Wasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haider","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,4]]},"reference":[{"key":"1536_CR1","unstructured":"World Health Organization Hepatitis Delta[http:\/\/www.searo.who.int\/EN\/Section10\/Section1027_9489.htm]"},{"key":"1536_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/141.5.590","volume":"141","author":"M Rizzetto","year":"1980","unstructured":"Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL: Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980, 141: 590-602. 10.1093\/infdis\/141.5.590","journal-title":"J Infect Dis"},{"key":"1536_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3201\/eid1209.060112","volume":"12","author":"FL Gal","year":"2006","unstructured":"Gal FL, Gault E, Rapault MP, Serpaggi J, Trinchet JC, Gordien E: Eight clade for hepatitis delta virus. Emerging Infect Dis 2006, 12: 1447-1450.","journal-title":"Emerging Infect Dis"},{"key":"1536_CR4","first-page":"169","volume-title":"Viral Hepatitis","author":"JL Gerin","year":"2002","unstructured":"Gerin JL, Cassey JL, Purcell RH: Hepatitis delta virus. In Viral Hepatitis. Edited by: Hollinger FB, Purcell RH,Gerin JL. Philadelphia: Lippincott Williams and Wilkins; 2002:169-182."},{"key":"1536_CR5","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1128\/JVI.78.5.2537-2544.2004","volume":"78","author":"N Radjef","year":"2004","unstructured":"Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T: Molecular phylogenetic analyses indicate a wide and ancient radiation African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004, 78: 2537-2544. 10.1128\/JVI.78.5.2537-2544.2004","journal-title":"J Virol"},{"key":"1536_CR6","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1128\/JCM.43.5.2363-2369.2005","volume":"43","author":"FL Gal","year":"2005","unstructured":"Gal FL, Gordien E, Affolabi D, Hanslik T, Alloui C, D\u00e9ny P: Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Micro 2005, 43: 2363-2369. 10.1128\/JCM.43.5.2363-2369.2005","journal-title":"J Clin Micro"},{"key":"1536_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/380454a0","volume":"380","author":"AG Polson","year":"1996","unstructured":"Polson AG, Bass BL, Casey JL: RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996, 380: 454-456. 10.1038\/380454a0","journal-title":"Nature"},{"key":"1536_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S1286-4579(02)01641-6","volume":"4","author":"Y Yamaguchi","year":"2002","unstructured":"Yamaguchi Y, Del\u00e9houz\u00e9e S, Handa H: HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation. Microb Infect 2002, 4: 1169-1175. 10.1016\/S1286-4579(02)01641-6","journal-title":"Microb Infect"},{"issue":"Suppl 1","key":"1536_CR9","doi-asserted-by":"publisher","first-page":"S212","DOI":"10.1016\/S0168-8278(03)00331-3","volume":"39","author":"P Farci","year":"2003","unstructured":"Farci P: Delta hepatitis: an update. J Hepatol 2003,39(Suppl 1):S212-S219.","journal-title":"J Hepatol"},{"key":"1536_CR10","first-page":"219","volume":"49","author":"P Husa","year":"2005","unstructured":"Husa P, Linhartov\u00e1 A, Nemecek V, Husov\u00e1 L: Hepatitis D. Acta Virol 2005, 49: 219-225.","journal-title":"Acta Virol"},{"key":"1536_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/infdis\/162.5.1170","volume":"162","author":"YF Liaw","year":"1990","unstructured":"Liaw YF, Chiu KW, Chu CM, Sheen IS, Huang MJ: Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis 1990, 162: 1170-1172. 10.1093\/infdis\/162.5.1170","journal-title":"J Infect Dis"},{"key":"1536_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/infdis\/158.4.795","volume":"158","author":"DM Novick","year":"1988","unstructured":"Novick DM: Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988, 158: 795-803. 10.1093\/infdis\/158.4.795","journal-title":"J Infect Dis"},{"key":"1536_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0168-8278(05)80629-4","volume":"21","author":"T Stroffolini","year":"1994","unstructured":"Stroffolini T: Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J Hepatol 1994, 21: 1123-1126. 10.1016\/S0168-8278(05)80629-4","journal-title":"J Hepatol"},{"key":"1536_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/JCM.01154-10","volume":"49","author":"Sy Chang","year":"2011","unstructured":"Chang Sy, Yang CL, Ko WS, Liu WC, Lin CY, Wu CS, Su YC, Chang SF, Chen MY, Sheng WH, Hung CC, Chang SC: Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan. J Clin Microbiol 2011, 49: 1083-1089. 10.1128\/JCM.01154-10","journal-title":"J Clin Microbiol"},{"key":"1536_CR15","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1440-1746.2005.03857.x","volume":"20","author":"K Mumtaz","year":"2005","unstructured":"Mumtaz K, Hamid SS, Adil S: Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 2005, 20: 1503-7. 10.1111\/j.1440-1746.2005.03857.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1536_CR16","first-page":"581","volume":"16","author":"BF Zuberi","year":"2006","unstructured":"Zuberi BF, Quraishy MS, Afsar S: Frequency and comparative analysis of hepatitis D in patients seeking treatment for hepatitis B. J Coll Physicians Surg Pak 2006, 16: 581-4.","journal-title":"J Coll Physicians Surg Pak"},{"key":"1536_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/329343a0","volume":"329","author":"S Makino","year":"1987","unstructured":"Makino S, Change MF, Sheikh CK, Kamahora T, Vannier DM, Govindarejin S: Molecular cloning and sequencing of a human delta virus RNA. Nature 1987, 329: 343-346. 10.1038\/329343a0","journal-title":"Nature"},{"key":"1536_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/infdis\/158.4.795","volume":"158","author":"DM Novick","year":"1988","unstructured":"Novick DM: Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988, 158: 795-803. 10.1093\/infdis\/158.4.795","journal-title":"J Infect Dis"},{"key":"1536_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0168-8278(05)80629-4","volume":"21","author":"T Stroffolini","year":"1994","unstructured":"Stroffolini T: Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J Hepatol 1994, 21: 1123-1126. 10.1016\/S0168-8278(05)80629-4","journal-title":"J Hepatol"},{"key":"1536_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JCM.01822-10","volume":"49","author":"Y Foupouapouognigni","year":"2011","unstructured":"Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R: High Prevalence and Predominance of Hepatitis Delta Virus Genotype 1 Infection in Cameroon. J Clin Microbiol 2011, 49: 1162-1164. 10.1128\/JCM.01822-10","journal-title":"J Clin Microbiol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:30:21Z","timestamp":1630513821000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-420","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,4]]},"assertion":[{"value":"25 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"420"}}